| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 64.897 | 58.202 | 73.665 | 46.559 | 66.559 | 43.846 | 5.666 | 41.037 | 42.555 | 53.569 |
| Total Income - EUR | 66.222 | 58.310 | 73.665 | 46.560 | 66.568 | 50.916 | 5.736 | 44.444 | 42.560 | 54.567 |
| Total Expenses - EUR | 47.801 | 46.239 | 62.779 | 66.634 | 50.716 | 24.557 | 4.448 | 19.269 | 24.573 | 73.273 |
| Gross Profit/Loss - EUR | 18.422 | 12.071 | 10.885 | -20.073 | 15.852 | 26.359 | 1.287 | 25.175 | 17.986 | -18.706 |
| Net Profit/Loss - EUR | 16.435 | 11.488 | 10.149 | -20.539 | 15.186 | 25.891 | 1.141 | 24.801 | 17.612 | -18.706 |
| Employees | 3 | 3 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Anoom Laboratories S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.977 | 7.822 | 5.161 | 2.630 | 2.618 | 0 | 0 | 243 | 126 | 0 |
| Current Assets | 14.233 | 15.238 | 21.106 | 14.609 | 19.402 | 38.492 | 14.458 | 50.102 | 78.483 | 66.814 |
| Inventories | 397 | 466 | 2.963 | 458 | 583 | 0 | 0 | 0 | 5.498 | 10.458 |
| Receivables | 7.026 | 9.238 | 11.601 | 11.116 | 12.925 | 12.573 | 13.803 | 49.491 | 71.351 | 53.985 |
| Cash | 6.810 | 5.534 | 6.542 | 3.035 | 5.895 | 25.919 | 655 | 611 | 1.633 | 5.657 |
| Shareholders Funds | -2.169 | 9.341 | 19.332 | -1.562 | 13.654 | 37.661 | 11.185 | 36.021 | 53.524 | 34.519 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 22.131 | 13.719 | 6.935 | 18.801 | 8.366 | 831 | 3.273 | 14.324 | 25.085 | 32.295 |
| Income in Advance | 2.250 | 2.672 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1089 - 1089" | |||||||||
| CAEN Financial Year |
1089
|
|||||||||
Comments - Anoom Laboratories S.r.l.